GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone
Summary
This summary is machine-generated.Glucocorticoid receptor beta (GRbeta) overexpression in nasal polyp inflammatory cells is linked to steroid insensitivity. This finding suggests GRbeta may be a key factor in persistent nasal polyposis unresponsive to topical steroids.
Area Of Science
- Immunology
- Otolaryngology
- Molecular Biology
Background
- Nasal polyposis (NP) is an inflammatory condition characterized by eosinophilic infiltration, often resistant to topical steroids.
- Overexpression of the glucocorticoid receptor splice variant GRbeta in inflammatory cells may contribute to steroid insensitivity in various inflammatory diseases.
Purpose Of The Study
- To investigate whether inflammatory cells in nasal polyps overexpress GRbeta.
- To determine if GRbeta overexpression correlates with insensitivity to fluticasone propionate (FP), a potent topical steroid.
Main Methods
- Biopsies from 10 nasal polyp patients before and after intranasal FP treatment.
- Middle turbinate biopsies from 6 healthy controls.
- Immunohistochemical staining for inflammatory markers and GRbeta; cytokine mRNA analysis; correlation of FP response with baseline GRbeta levels.
Main Results
- Nasal polyps showed increased inflammatory cells, with a significantly higher percentage expressing GRbeta (40.5% vs 16.1%).
- GRbeta expression was primarily in T lymphocytes, eosinophils, and macrophages.
- Higher baseline GRbeta expression inversely correlated with FP's effectiveness in reducing eosinophils, T cells, VCAM-1, and IL-4 mRNA; 'FP-insensitive' NPs had higher GRbeta expression.
Conclusions
- GRbeta expression in nasal polyp inflammatory cells serves as a marker for steroid insensitivity.
- GRbeta expression, particularly in T cells and eosinophils, may confer resistance to topical steroids, perpetuating NP inflammation.
View abstract on PubMed